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Abstract
Aim-TQ determine whether iron metabolism influences the incidence of systemic fungal infection in patients with haematological malignancies. Methods-The study population comprised 74 patients who had undergone myeloablative chemotherapy. Systemic fungal infections were classified as confirmed (histological confirmation or characteristic septate hyphae) or possible (antibiotic resistant fever which resolved foliowing administration of intravenous amphotericin B, together with either typical radiographic lesions or massive oropharyngeal candidiasis). Parameters of iron metabolism included serum iron concentrations, total iron binding capacity, serum 10 and some authors have suggested that there is an association between reduced total iron binding capacity (TIBC) and fungal infection in patients with acute non-lymphoblastic leukaemia.11 12 The aim of this study was to determine whether iron metabolism differs in various types of haematological malignancies and whether such differences are associated with a higher incidence of fungal infection. On comparing iron metabolism in patients with and without fungal infection (25 and 53 cases, respectively) (table 2), the former group had significantly increased serum iron concentrations (p = 0-01), a lower TIBC, and serum transferrin concentration (p = 0-001), while transferrin saturation values and serum ferritin concentrations were significantly increased (p = 0001). Iron concentrations in patients with confirmed infection on biopsy were even higher than in those diagnosed clin- A possible explanation for the increase in ferritin concentrations detected in 'both AML and ALL is that the blast cells could be actively synthesising ferritin and releasing it into the serum.'3 14 Increased transferrin saturation values could result from a decrease in transferrin concentrations without a parallel decrease in the serum iron concentration.' The decrease in transferrin concentrations can be explained as an acute phase reactant protein response, characteristic of chronic disorders. In contrast to other tumours, serum iron concentrations were slightly raised in patients with acute leukaemia, which may be at least partially attributed to a decrease in iron consumption caused by diminished bone marrow cell erythropoietic activity.5 An additional and probably a more important factor is the transfer of iron from ferritin to transferrin in the circulation. '5 Iron is an essential nutrient for opportunistic fungi. They may even use iron from iron binding proteins to generate siderophores,'6 17 or use external siderophores produced by other micro-organisms, such as desferrioxamina which is generated by Streptomyces pilosus.8 '19 As far as iron metabolism in pathogenic fungi is concerned, transferrin not only plays an indirect role in iron transport, but could also have a direct effect by binding directly to filomentous fungi.20
Methods
To investigate whether iron metabolism affects the incidence of systemic fungal infection, we compared iron metabolism in patients with and without fungal infection overall and in each of three groups of haema-Iron metabolism andfungal infections in patients with haematological malignancies tological disorders. On diagnosis, patients with fungal infection had substantially increased transferrin saturation values and ferritin concentrations, together with low serum transferrin and high serum iron concentrations. This pattern was observed in patients with AML and ALL as well as in those with chronic lymphoproliferative disorders. In the latter group, however, the increase in transferrin saturation values and ferritin concentrations was not as noticeable.
Our observations confirm those of Karp and Mertz"2 who reported an association between reduced TIBC and fungal infection in patients with acute myeloblastic leukaemia. Our findings also show that the risk of sustaining mycoses with increased transferrin saturation values is not exclusive to AML, but can be extended to all malignant haematological disorders and that the fungal infection may be either candidiasis or aspergillosis. This is consistent with in vitro studies which demonstrated that increases in transferrin saturation values910 and decreases in serum transferrin concentrations20 abolish fungistatic activity in serum.
Factors promoting the development of systemic fungal infection in patients with haematological malignancies include neutropenia, compromised immunity, and treatment with broad spectrum antibiotics. The increase in transferrin saturation values is probably an additional risk factor which, when associated with those listed previously, predisposes the patient to systemic fungal infection. Increases in transferrin saturation values probably promote fungal growth by increasing the supply of iron. One possible host defensive mechanism would be to block this supply by keeping iron either bound to apotransferrin and apolactoferrin in the extracellular space or as intracellular ferritin and hemosiderin.2' Saturation of extracellular proteins facilitates the release of iron and favours its presence in the free state in serum. 22 Another less likely possibility is that unsaturated transferrin could have fungistatic activity20 and that saturation with iron could abolish such activity.9 10 In conclusion, our results suggest that there may be a correlation between fungal infection and iron metabolism and that apotransferrin may be of use in the prophylaxis and treatment of such infections.
patients with haematological malignancies. 
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